NORTHERN TRUST CORP - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$491,656
-34.0%
221,467
+1.1%
0.00%
Q2 2023$744,773
-1.2%
219,051
+15.9%
0.00%
Q1 2023$754,098
-24.3%
188,997
+3.2%
0.00%
Q4 2022$996,646
+8.0%
183,207
-0.2%
0.00%
Q3 2022$923,000
+39.0%
183,616
+5.4%
0.00%
Q2 2022$664,000174,1290.00%
Other shareholders
TRANSPHORM INC shareholders Q1 2023
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 609,170$4,307,0001.99%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 374,226$2,646,0001.61%
Kohlberg Kravis Roberts & Co. L.P. 22,175,980$156,784,0001.42%
Foundation Capital, LLC 136,004$962,0000.62%
Soros Fund Management 673,991$4,765,0000.07%
Polar Asset Management Partners Inc. 867,500$6,133,0000.07%
ExodusPoint Capital Management, LP 89,499$633,0000.01%
AMERIPRISE FINANCIAL INC 3,602,481$25,470,0000.01%
Weiss Asset Management LP 43,600$308,0000.01%
Ergoteles LLC 18,900$134,0000.01%
View complete list of TRANSPHORM INC shareholders